Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
gut-driven MCAS) MTHFR, HNMT, MAOA SNPs Influence histamine clearance and neurotransmitter sensitivity Cytokine panel (IL-6, TNF-, IL-1) Indicates immune overactivation OAT (Organic Acids Test) May show clostridia overgrowth, mold, or neurotransmitter imbalances Stool testing (GI-MAP) Identifies pathogens or dysbiosis triggering mast cells Mycotoxin or mold panel Mold exposure is a major MCAS trigger Step 4: Diagnostic Criteria (per 2012 Consensus) A diagnosis of MCAS is made when all three of the following are met: Typical clinical symptoms affecting 2 organ systems Elevated mast cell mediator(s) during episodes (tryptase, histamine, prostaglandins, etc.) Clinical response to MCAS treatments , including antihistamines, cromolyn sodium, quercetin, or mast cell stabilizers Genetic Variants Associated with MCAS Susceptibility MCAS (Mast Cell Activation Syndrome) is not caused by a single gene mutation , but certain genetic variants can increase your susceptibility by impairing detoxification, immune regulation, or histamine metabolism
Our services are cash-pay, which means no surprise bills or coverage gaps - and you get full transparency on cost
continued improvement for chronic Weeks 8-12: Maximum benefit achieved
What deficiency causes low platelets
Our products are compounded at an FDA approved 503B outsourcing facility that meets the strict 503B sterile compounding guidelines
US$ 27.82
US$ 21.24
US$ 25.31
US$ 20.23
US$ 29.90
